VelosBio
2 known investors
A biopharmaceutical company developing medicines and vaccines with a focus on clinical research and development for human health.
Investors · 2
In the news
- VelosBio - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Merck to pay almost $3B for VelosBio, broadening antibody cancer drug push | BioPharma Divebiopharmadive.com · 2020
- VelosBio Raises $137 Million Series B Funding For Cancer Drug Development - San Diego Business Journalsdbj.com · 2020
- VelosBio Raises $137M in Series B Financing - FinSMEsfinsmes.com · 2020
- VelosBio Raises $137 Million in Series B Financing to Advance Development of ROR1-Directed Therapeutics in Oncology - BioSpacebiospace.com · 2020
- VelosBio Emerges with $58M in Funding to Steer Cancer Drugs to Clinic - Pappas Capitalpappas-capital.com · 2018